A single-cell survey of cellular hierarchy in acute myeloid leukemia

Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput single-cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hematology and oncology 2020-09, Vol.13 (1), p.128-128, Article 128
Hauptverfasser: Wu, Junqing, Xiao, Yanyu, Sun, Jie, Sun, Huiyu, Chen, Haide, Zhu, Yuanyuan, Fu, Huarui, Yu, Chengxuan, Weigao, E., Lai, Shujing, Ma, Lifeng, Li, Jiaqi, Fei, Lijiang, Jiang, Mengmeng, Wang, Jingjing, Ye, Fang, Wang, Renying, Zhou, Ziming, Zhang, Guodong, Zhang, Tingyue, Ding, Qiong, Wang, Zou, Hao, Sheng, Liu, Lizhen, Zheng, Weiyan, He, Jingsong, Huang, Weijia, Wang, Yungui, Xie, Jin, Li, Tiefeng, Cheng, Tao, Han, Xiaoping, Huang, He, Guo, Guoji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Acute myeloid leukemia (AML) is a fatal hematopoietic malignancy and has a prognosis that varies with its genetic complexity. However, there has been no appropriate integrative analysis on the hierarchy of different AML subtypes. Methods Using Microwell-seq, a high-throughput single-cell mRNA sequencing platform, we analyzed the cellular hierarchy of bone marrow samples from 40 patients and 3 healthy donors. We also used single-cell single-molecule real-time (SMRT) sequencing to investigate the clonal heterogeneity of AML cells. Results From the integrative analysis of 191727 AML cells, we established a single-cell AML landscape and identified an AML progenitor cell cluster with novel AML markers. Patients with ribosomal protein high progenitor cells had a low remission rate. We deduced two types of AML with diverse clinical outcomes. We traced mitochondrial mutations in the AML landscape by combining Microwell-seq with SMRT sequencing. We propose the existence of a phenotypic "cancer attractor" that might help to define a common phenotype for AML progenitor cells. Finally, we explored the potential drug targets by making comparisons between the AML landscape and the Human Cell Landscape. Conclusions We identified a key AML progenitor cell cluster. A high ribosomal protein gene level indicates the poor prognosis. We deduced two types of AML and explored the potential drug targets. Our results suggest the existence of a cancer attractor.
ISSN:1756-8722
1756-8722
DOI:10.1186/s13045-020-00941-y